This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hybio Pharmaceutical Co., Ltd.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations of Hongling Li in Pharmaceutical Chemistry
Introduction
Hongling Li is a notable inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of atosiban acetate. His innovative methods have the potential to enhance the efficiency of drug production.
Latest Patents
Hongling Li holds a patent for a method for preparing atosiban acetate. The invention outlines a process that includes synthesizing linear atosiban, dissolving it in an acetonitrile aqueous solution, adjusting the pH with ammonia water, and employing oxidation techniques. This method addresses the challenges of insolubility associated with linear atosiban, while also optimizing reaction size and time, resulting in high yield and industrial applicability.
Career Highlights
Li is associated with Hybio Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical innovations. His work has been instrumental in advancing methods that improve drug formulation and production processes.
Collaborations
Hongling Li collaborates with esteemed colleagues such as Qing Xiao and Jian Hui Liu, contributing to a dynamic research environment that fosters innovation in pharmaceutical sciences.
Conclusion
Hongling Li's contributions to the field of pharmaceutical chemistry, particularly through his patent for atosiban acetate, exemplify the impact of innovative methods in drug development. His work continues to influence the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile